Abiopharma

🔍 Friedman Douglas (Executive)

Company: Tradeweb Markets Inc. (TW)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Sold 2,219 shares of Class A common stock at $125.1235 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,513.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 592 shares of Class A common stock at $124.86 per share (Direct)
  Date: 2026-03-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 13,921.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 3, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.03 to $125.78, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: This amount includes (i) 1,990 unvested restricted stock units ("RSUs") in respect of the issuer's Class A common stock ("Class A Common Stock") that are scheduled to vest on March 15, 2027, (ii) 2,421 unvested RSUs in respect of Class A Common Stock that are scheduled to vest in equal installments on March 17, 2027 and March 17, 2028 and (iii) 6,510 unvested RSUs in respect of Class A Common Stock that are scheduled to vest on March 15, 2027, March 15, 2028 and March 15, 2029, in each case, subject to the reporting person's continued employment through the applicable vesting date.